Biomedicine and Pharmacotherapy

SJR Rank #1,337H-index: 196SJR: 2.074Best quartile: Q1Open AccessAPC: US$3,610
Journal website: aims, scope and author guidelines
Publisher

Elsevier Masson s.r.l.

Country

France

Type

journal

SJR by Edition

2022202500.551.11.652.2

Subject Categories

  • Medicine (miscellaneous)Q1
  • PharmacologyQ1

Areas: Medicine · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Cancer-related molecular mechanisms researchMicroRNA in disease regulationCircular RNAs in diseasesRNA modifications and cancerAutophagy in Disease and TherapyLiver Disease Diagnosis and TreatmentCancer, Hypoxia, and MetabolismGenomics, phytochemicals, and oxidative stressPharmacological Effects of Natural CompoundsNatural Antidiabetic Agents Studies

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs01500300045006000

Documents per Year

20222025040080012001600

Detailed Information

ISSN

0753-3322, 1950-6007

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

9.84

References per Document

82.70

Coverage

1982-2026

Scope

Biomedicine & Pharmacotherapy is a multidisciplinary journal which publishes full-length, original research reports, reviews, and preliminary communications or letters to the editor which fall within the general scope of clinical and basic medicine and pharmacology. The general fields of interest will include Cancer, Nutriceutics, Neurodegenerative, Cardiac and Infectious Diseases. Special emphasis will be placed on studies of specific topics such as molecular mechanisms, gene regulation in normal and pathologic cells as well as susceptibility in response to oncogenic agents. Effects of drugs on preclinical and clinical pharmacology and the role of bacteria, viruses and parasites in animals and humans. Brief reports of meetings, symposia and conferences will also be considered for publication as well as brief listings of scientific meetings or academic courses of interest to the readers

Metrics from SCImago Journal Rank 2025. View on SCImago